Genfit SA
3.5520
29-April-25 11:29:43
15 minutes delayed
Stocks
+0.1440
+4.23%
Today's range
3.4000 - 3.5520
ISIN
FR0004163111
Source
Cboe
-
10 Jun 2024 17:22:00 By Nasdaq GlobeNewswire
-
GENFIT to Present Latest ACLF Research at EASL Congress™ 2024
29 May 2024 16:10:00 By Nasdaq GlobeNewswire
-
GENFIT: May 22, 2024 Combined Shareholders Meeting Results
22 May 2024 12:05:00 By Nasdaq GlobeNewswire
-
GENFIT Reports First Quarter 2024 Financial Information
14 May 2024 16:10:00 By Nasdaq GlobeNewswire
-
GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023)
25 Apr 2024 16:10:00 By Nasdaq GlobeNewswire
-
GENFIT Annual Combined General Meeting of May 22, 2024 — Availability of Preparatory Documents
15 Apr 2024 16:10:00 By Nasdaq GlobeNewswire
-
05 Apr 2024 14:00:00 By Nasdaq GlobeNewswire
-
GENFIT Reports Full-Year 2023 Financial Results and Provides Corporate Update
04 Apr 2024 16:10:00 By Nasdaq GlobeNewswire
-
GENFIT Announces Revenues and Cash Position as of December 31, 2023
29 Feb 2024 16:10:00 By Nasdaq GlobeNewswire
-
GENFIT Announces 2024 Financial Calendar
15 Jan 2024 16:10:00 By Nasdaq GlobeNewswire
-
GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
11 Jan 2024 16:10:00 By Nasdaq GlobeNewswire
-
08 Dec 2023 01:55:00 By Nasdaq GlobeNewswire
-
07 Dec 2023 05:15:01 By Nasdaq GlobeNewswire
-
06 Dec 2023 11:30:00 By Nasdaq GlobeNewswire
-
GENFIT Highlights ACLF Development Strategy at “ACLF Day” during AASLD The Liver Meeting® 2023
16 Nov 2023 16:10:00 By Nasdaq GlobeNewswire
-
GENFIT Reports Third Quarter 2023 Financial Information
09 Nov 2023 16:10:00 By Nasdaq GlobeNewswire
-
GENFIT to Present Update on Scientific and Corporate Progress at The Liver Meeting® 2023
02 Nov 2023 17:10:00 By Nasdaq GlobeNewswire
-
26 Sep 2023 16:10:00 By Nasdaq GlobeNewswire
-
GENFIT Reports First Half-Year 2023 Financial Results and Provides Corporate Update
20 Sep 2023 16:10:00 By Nasdaq GlobeNewswire